Liver Tumor
Conditions
Brief summary
Centralized biological collection of multicentric origin, retrospective and prospective of biological samples (tissues and fluids) taken within the framework of the diagnostic and therapeutic management of children and adolescents with liver tumor, and supported in the centers of French Society for Childhood Cancers (SFCE) with associated clinical database.
Interventions
None listed
Sponsors
Gustave Roussy, Cancer Campus, Grand Paris
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
No minimum to 18 Years
Inclusion criteria
1. \- For inclusion in the clinical database: * Children and adolescents (≤18 years at diagnosis) suffering from a primary liver tumor diagnosed after 01/01/1990 and treated in France * Informed consent to the computerization of data signed by the patient or by parents or legal representatives if he is a minor. 2. \- For inclusion in the biological collection (CRB Paris Sud): * Additional criteria: * Availability of biological samples (tumor tissue, healthy tissue, plasma and / or serum). * Informed consent to the use of biological remains signed by the patient or by parents or legal representatives if he is a minor. 3. \- For the inclusion of deceased patients: * Obtaining consent or failing this, seeking non-opposition to the computerization of data (for inclusion in the database) and the use of biological remains (for inclusion in the biological collection) of the patient or both parents or the legal guardian if he is a minor.
Exclusion criteria
* None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Establish a national bank of rare biological material | Up to 10 years |
Countries
France
Contacts
Primary ContactBrenda Mallon
Outcome results
None listed